Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$15.50 USD
+0.20 (1.31%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $15.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: AMC |
9/2024 | $-1.07 | 0.00% |
Earnings Summary
For their last quarter, Arcus Biosciences (RCUS) reported earnings of -$1.02 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for RCUS's next earnings release on November 06, 2024. For the next earning release, we expect the company to report earnings of -$1.07 per share, reflecting a year-over-year decrease of 13.83%.
Earnings History
Price & Consensus
Zacks News for RCUS
Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for
RCUS: What are Zacks experts saying now?
Zacks Private Portfolio Services